Charles River is pleased to participate in the scientific program at the 2019 Alzheimer's Association International Conference (AAIC). Stop by booth 717 to meet our global staff of neuroscience specialists and learn about new approaches and methodologies in the pursuit of Alzheimer therapies, including:
- PET and CSF markers of neuroinflammation
- Alzheimer's disease (AD) blood-based biomarkers and AD control
- Fluid biomarkers of inflammation
- Imaging neurodegeneration with MRI
Offering a comprehensive selection of dedicated animal models, screening studies, translational tools, and disease-relevant endpoints, Charles River can support your Alzheimer's research from early discovery through safety.
Want to set aside dedicated time to discuss your program with our team? Request a meeting by send an email to [email protected].
Characterization of Tau-expressing P301S Mouse Model for Tauopathy -- Longitudinal Structural, Functional, and Metabolic Profiling of the Brain
Jukka Puoliväli, Juho Oksman, Kimmo Lehtimäki, Tuulia Huhtala, Jussi Rytkönen, Taina-Kaisa Stenius, Artem Shatillo, Diana Miszczuk, Antti Nurmi
Faster Responding of TG2576 Mice in the Touch Screen Version of the Progressive Ratio Task
Joni P. Jarvenpaa, Maksym V. Kopanitsa, Diana Miszczuk, Juho Oksman, Jukka Puolivali
Effects of Antioxidant Treatment in a Mouse Model of Alzheimer's: a Behavioral Phenotyping and Microdialysis study
Marie Monbureau, Ayma F. Malik, Patrick N..J Northey, Julien Roeser, Emily Holland, Claudio Ciardiello, Nadege Morisot, Marleke G. van der Hart, Holden B. Janssens, Arash Rassoulpour